Zelta user success stories: Less stress, lower database costs, and fast-tracked clinical trials

We’re profiling another selection of CROs and pharma companies using Zelta. Check out their success stories of how they’ve used the platform to create less stress, lower database costs, and fast-tracked clinical trials. 

Sysmex: Bringing database builds in-house reduced stress 

Sysmex is one of the biggest names in the hematology space. If you’ve had your blood drawn, odds are that it was tested on a Sysmex analyzer – a point of pride for this medical device company. And all the more reason why running streamlined clinical trials on what are complicated, diverse sets of sample data is so imperative.  

Prior to working with Zelta, Sysmex had partnered with a CRO to manage their databases. That relationship proved to be more challenging than expected. Sysmex runs their trials on many samples, but the CRO could not build and tune databases capable of running those samples to Sysmex’s satisfaction. Sysmex wanted more control over their database builds; they wanted data collection to be more streamlined; and they wanted to bring the process in-house to achieve that. They turned to Zelta to do just that.  

The first Sysmex study built on the Zelta platform took just four weeks – significantly speedier than previous studies built on other platforms that could take up to 12 weeks. Although, given the complexity and diversity of studies, these times are not 100% comparable. What became clear to Sysmex right away was just how much time could be saved using Zelta going forward.  

Between the streamlined data collection, greater control over building and viewing databases, an easier query system, and overall more user-friendly experience, Sysmex is looking to expand its use of Zelta to more studies in the future – an ambition made easier by the consistent communication and resources provided by the Zelta team.  

Trust me when I say, our team was very relieved when we brought data management in-house to have more control over data collection. Using Zelta has been great, it has eliminated the stress factor we had with our last vendor. Now we’re able to build and manage databases to our satisfaction and Zelta makes that possible.”

– Tserundede Ekwue, MD, Sr Manager, Clinical Data Management, Clinical Affairs, Sysmex

Fast-Track Drugs and Biologics: Fast tracking clinical trials with ePRO and self-service 

Katrina Riggs, Chief Operating Officer for Fast-Track Drugs and Biologics, shares how her team has leveraged Zelta's ePRO capabilities and self-service support to accelerate clinical trials with dozens of patient-reported outcomes and put their clients' data management needs and drug development processes on the fast track. Check out her testimonial.  

KCRI: Leveraging an all-in-one design within a single EDC platform 

KCRI is a CRO with expertise in comprehensive clinical trial management with a MedTech focus, and chose the Zelta system for its quality and user-friendly design. 

Veristat: Cutting gene therapy trial database costs by up to 30% 

Genetic disorders that can be treated with gene therapy are often extremely rare (some affect just one person out of a million), meaning gene therapy trials are limited by the number of patients available to them – and making accurate data collection during these trials absolutely vital. Electronic data capture (EDC) is one of the best means for reducing efficiencies, streamlining data capture, and optimizing trial results, but it’s hard for a typical EDC solution to capture all the data needed, and adapt to changes as they arise, during a gene therapy trial. And because these CGT trials pull from a limited pool of patients, the prospect of patient drops can end up leading to serious disruptions and costly delays for the trial.  

That’s what led Veristat to use Zelta’s cloud-based EDC platform for their gene therapy trials. The flexibility and scalability of the Zelta platform, allowing users to choose the modules they want for their study, makes it compatible for all trial types regardless of complexity or size. Zelta features like flexible page layouts and automated queries allow it to manage highly complex data collection processes in CGT trials without compromising the user experience. This enabled Veristat to cut down on their clinical database costs by up to 30%, while also reducing build time for CGT trial databases from 10 weeks to eight or less.  

Zelta’s ePRO integrated with EDC functionality also allowed Veristat to reduce the burden of tech integrations needed in their trials, making it easier to manage patient data and create more engaging trial experiences for the patients.  

“Being able to shave a couple of weeks off a trial’s schedule is huge for us. We save on costs, and it also leads to the quicker launch of a product, which is highly meaningful for those affected by diseases.” 

– Nan Shao 
Executive Vice President of Global Operations, Veristat 

Take the next step 

Did any of these stories feel familiar to you? Now that you’ve read about how other organizations like yours were able to use Zelta to streamline their clinical trials and achieve new efficiency gains and cost reductions, take the next step with an interactive Zelta demo. In a few clicks you’ll gain a comprehensive view of how to build studies in Zelta EDC, drill down into the study build features, and see for yourself how Zelta allows you to customize study builds to your trial’s needs. 

Try the Zelta demo